What treatment strategies are being used in relapsed acute lymphoblastic leukemia?

Elias Jabbour

During the European School of Haematology (ESH) 2nd Translational Research Conference: Acute Lymphoblastic Leukaemia, Know ALL spoke to Elias Jabbour, MD Anderson Cancer Center, Houston, US.

We asked, What treatment strategies are being used in relapsed acute lymphoblastic leukemia? In this video, Jabbour explains how we have been able to increase survival and remission rates through a targeted approach, using new drugs like bispecific T-cell engagers (BiTEs) and chimeric antigen receptor (CAR) T-cells. He highlights that the outcomes of patients with relapsed acute lymphoblastic leukemia have been improving significantly and will continue to do so.

All content on Know All is primarily intended for patients and caregivers. If you are a healthcare professional, please visit the ALL Hub.

Please get in touch if you have any questions about Know All or if you would like to discuss a potential collaboration.

Brought to you by

Scientific Education Support

In collaboration with

Thank you to the funders of Know ALL. All content is developed independently by SES in collaboration with an expert ambassador group; funders are allowed no influence on the content of Know ALL.

GOLD

BRONZE